Thoratec Corporation (THOR)

29.93 -0.41  -1.35%  Jun 01, 10:01AM Go Pro
Watch this stock
View Full Chart THOR Price Chart

Key Stats

Market Cap 1.749B
Revenue Growth 27.37%
Profit Margin 20.10%
Earnings Yield 4.51%
Dividend Yield 0.00%
Earnings Per Share TTM 1.35
PE Ratio 22.17
Price / Sales Ratio 3.887
52 Week High 38.07
52 Week Low 27.84
Beta 0.7741
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 30 Here's How Thoratec Is Making You So Much Cash Fool
May 29 THORATEC CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May 29 Abiomed Reiterated at Outperform
May 25 HeartWare Product Makes Headway
May 23 CAPScall of the Week: Heartware International Fool
May 22 Thoratec Remains Neutral
May 22 Lazard downgrades Abiomed on Impella reimbursement concerns
May 18 Barclays on Medical Supplies & Devices: Continue To Favor Stocks with Potential Produ...
May 17 Abiomed Beats, Posts Profit
May 15 Check this for a Glimpse of Thoratec's Future Fool
May 02 Notable Earnings Gappers Up = $TRIP $MTOR $TRLG $FORM $THOR $WCG $VOCS $STRI $GNW $OCZ $ENR $RGR $VG $CBS $CVS $FBC All up 2% or more by 1973Hog
May 01 Listen to $THOR Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3bvF by earningscast
Apr 27 Rival heart pump makers $ABMD and $THOR get a boost after FDA panel recommends HeartWare's HVAD device for approval. http://stks.co/3YBD by abubnic
Apr 26 HIGH $PUT VOLU $IPG 1361% $JNS 1080% $UTHR 1060% $HRB 968% $THOR 809% $OMC 709% $ETFC 627% $CRUS 552% $OII 542% $WPI 535% by livevol_pro
Apr 26 $THOR is 5.2% up since open on unusual high volume and 3.9% up since close. by TradeBot

Profile

Exchange: NASDAQGS       Sector: Healthcare       Industry: Medical Instruments & Supplies

Thoratec Corporation is a United States-based company that designs, manufactures, sells, and supports products that treat a wide range of clinical needs for advanced heart failure patients, specifically proprietary medical devices for circulatory support, vascular graft applications, point-of-care diagnostic test systems, and skin incision products. Headquartered in Pleasanton, California, U.S.A., its product lines include the Thoratec VAD and HeartMate LVAS. Thoratec’s devices are implanted in patients with advanced heart failure worldwide. The company was founded in March 1, 1976.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Thoratec Corporation is down 11.34% over the last year vs S&P 500 Total Return down 0.41%, Heartware International up 14.85%, and ABIOMED up 8.64%.

  • THOR Total Returns
  • ^SPXTR Total Returns
  • HTWR Total Returns
  • ABMD Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring THOR

Did Thoratec Corporation make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

THOR Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
THOR 29.93 -0.41 -1.35% 1.773B
THO 29.35 -1.40 -4.55% 1.686B
THM 3.54 +0.30 +9.26%
THLD 7.10 -0.23 -3.14% 377.71M
THI 52.28 -1.02 -1.91% 8.441B
THG 38.38 -0.63 -1.61% 1.756B
SWM 65.83 -1.07 -1.60% 1.066B
SWKS 26.11 -0.75 -2.79% 5.061B
SWK 64.39 -1.86 -2.81% 11.29B
SWIR 8.90 -0.08 -0.89% 278.11M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close